COVID-19 Pandemisi Sürecinde Tip 2 Diyabetli Bireylerin Vitamin-Mineral ve Bitkisel Ürün Kullanımlarının Değerlendirilmesi: İzmir İli Örneği Kesitsel Araştırma

Amaç: Bu araştırmanın amacı, COVID-19 pandemi sürecinde tip 2 diyabetli bireylerin vitamin-mineral ve bitkisel ürün kullanımlarının değerlendirilmesidir. Gereç ve Yöntemler: Kesitsel ve tanımlayıcı tipteki bu araştırma, İzmir ilinde yaşayan 246 tip 2 diyabetli birey ile yürütülmüştür. Bireylerin sosyo-demografik özellikleri, vitamin-mineral ve bitkisel ürün kullanımları sorgulanarak anket formuna kaydedilmiştir. Bireylerin vücut ağırlığı (kg) ve boy uzunluğu (cm) ölçülerek, Beden kütle indeksi (BKİ, kg/m2) hesaplanmıştır. Bulgular: Bireylerin yaş ortalaması 54,68 ± 8,62 yıl olup, %26’sı erkek (n=64), %74’ü kadındır (n=182). COVID-19 öncesi dönemde vitamin-mineral kullananların oranı %36,6 (n=90) iken, bu oran COVID-19 sürecinde anlamlı artış göstermiştir (%52,4; n=129; p<0,001). COVID-19 sürecinde kullanım oranı anlamlı olarak artan besin destekleri D vitamini (Pandemi öncesi: %19,1; Pandemi süreci: %32) ve magnezyum (Pandemi öncesi: %3,7; Pandemi süreci: %8,5) olarak belirlenmiştir (p<0,05). Bitkisel ürün kullanım oranında da COVID-19 sürecinde (%82,1; n=202) COVID-19 öncesine (%75,6; n=186) kıyasla anlamlı artış görülmüştür (p<0,05). Kullanım oranı COVID-19 sürecinde anlamlı artış gösteren bitkisel ürünler zencefil (Pandemi öncesi: %42,3; Pandemi süreci: %46,7) ve zerdeçal (Pandemi öncesi: %41,1; Pandemi süreci: %45,1) olarak belirlenmiştir. Katılımcıların ortalama BKİ değeri COVID-19 öncesinde 31,50 ± 6,25 kg/m2 iken, anlamlı azalma göstererek COVID-19 sürecinde 31,02±5,99 kg/m2 bulunmuştur (p=0,020). Sonuç: Tip 2 diyabetliler arasında, vitamin-mineral ve bitkisel ürün kullanımının pandemi sürecinde pandemi öncesine göre daha yaygın olduğu belirlenmiş, bu süreçte diyabetli bireylerin beden kütle indekslerinin azaldığı ortaya konmuştur.

Anahtar Kelimeler:

Bitkisel ürün, COVID-19, Diyabet, Vitamin, Mineral

Evaluation of Vitamin-Mineral and Herbal Product Uses of Individuals with Type 2 Diabetes During the COVID-19 Pandemic

Aim: The aim of this study was to evaluate the use of vitamins, minerals and herbal products in individuals with type 2 diabetes during the COVID-19 pandemic. Material and Methods: This cross-sectional and descriptive study was conducted with 246 individuals with type 2 diabetes living in Izmir. Sociodemographic features, vitamin-mineral and herbal products use of participants were recorded with a questionnaire form. The body weight (kg) and height (cm) were measured, and the body mass index (BMI, kg/m2) was calculated. Results: 74.0% (n=182) of participants were woman, 26.0% (n=64) were man, and the mean age was 54.68±8.62 years. While the proportion of those who used vitamins and minerals prior to COVID-19 was 36.6% (n=90), this ratio increased significantly during the COVID-19 process (52.4%; n=129; p<0.001). Vitamin D (before pandemic:19.1%, during pandemic: 32.0%) and magnesium (before pandemic: 3.7%, during pandemic: 8.5%) were identified as nutritional supplements whose utilization rate increased significantly during the pandemic (p<0.05). The use of herbal products increased significantly during the pandemic (82.1%; n=202) compared to before pandemic (75.6%; n=186) (p<0.05). The herbal products whose usage rate increased significantly during the pandemic were determined as ginger (before pandemic: 42.3%; during pandemic: 46.7%) and turmeric (before pandemic: 41.1%; during pandemic: 45.1%). While the participants’ mean BMI was 31.50±6.25 kg/m2 prior to pandemic, it decreased significantly and was found to be 31.02±5.99 kg/m2 during the pandemic (p=0.020). Conclusion: It was discovered that the use of vitamins, minerals, and herbal products was more common among type 2 diabetics during the pandemic period than before the pandemic, and that the body mass indexes of individuals with diabetes decreased during this process.

Keywords:

Herbal products, COVID-19, Diabetes, Vitamin-mineral,

PDF

___

1. Çulfa S, Yıldırım E, Bayram B. COVID-19 pandemi süresince insanlarda değişen beslenme alışkanlıkları ile obezite ilişkisi. Online Türk Sağlık Bilimleri Dergisi. 2021;6(1):135-142.
2. International Diabetes Federation. IDF Diabetes Atlas, 10th Edition. Brussels, Belgium: 2021. Available at: https:// diabetesatlas.org/idfawp/resource-files/2021/07/IDF_ Atlas_10th_Edition_2021.pdf
3. Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546-550.
4. Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020;36(7):e33213321.
5. Kutlutürk F. COVID-19 pandemisi ve diabetes mellitus. Türkiye Diyabet ve Obezite Dergisi. 2020;4(2):130-137.
6. Arslan K, Baş S. COVID-19 and Diabetes - Prevalence and Prognosis: A Single-Center Experience. Turk J Diab Obes 2021;2: 180-185.
7. Çakmak R, Telci Çaklılı Ö, Ok A, Mutlu Ü, Sarıbeyliler G, Seferova Nasifova V, Medetalibeyoğlu A, Şenkal N, Çatma Y, Köse M. COVID-19 and diabetes mellitus: Are there any differences in outcomes with anti-diabetic drugs? Turk J Diab Obes 2021;3: 279-284.
8. World Health Organization (WHO). Nutrition advice for adults during the COVID-19 outbreak. 2021. (Accessed November 2021). Available at: https://www.emro.who.int/ nutrition/covid-19/nutrition-advice-for-adults-during-thecovid- 19-outbreak.html
9. Adams KK, Baker WL, Sobieraj DM. Myth busters: Dietary supplements and COVID-19. Ann Pharmacother. 2020;54(8):820-826.
10. Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020;12(4):1181.
11. Demir G, Kılıçkalkan B, Takak MK. COVID-19 pandemisi sürecinde yetişkinlerin besin destekleri kullanımlarının incelenmesi. Genel Tıp Dergisi. 2021;31(4):430-439.
12. Abdullah Alotiby A, Naif Al-Harbi L. Prevalence of using herbs and natural products as a protective measure during the COVID-19 pandemic among the Saudi population: An online cross-sectional survey. Saudi Pharm J. 2021;29(5):410-417.
13. Dost A, Üner E, Susoy A. COVID-19 pandemisi besin desteklerini kullanma durumunu etkiledi mi? Van Tıp Dergisi. 2021;28(4):538-545.
14. Bellikci Koyu E. Diyabette kullanılan bitkisel desteklerin etkinliği ve güvenilirliği. Bes Diy Derg. 2019;47(Özel Sayı):110- 117.
15. Hamulka J, Jeruszka-Bielak M, Górnicka M, Drywień ME, Zielinska-Pukos MA. Dietary supplements during COVID-19 outbreak. Results of google trends analysis supported by PLifeCOVID-19 online studies. Nutrients. 2020;13(1):54.
16. T. C. Sağlık Bakanlığı. Türkiye Beslenme ve Sağlık Araştırması (TBSA). Ankara: 2019. Available at: https://hsgm.saglik.gov.tr/ depo/birimler/saglikli-beslenme-hareketli-hayat-db/Yayinlar/ kitaplar/TBSA_RAPOR_KITAP_20.08.pdf
17. Samar E. Pandemi sürecinde spor salonlarında egzersiz yapan kişilerde gıda takviyesi kullanma durumunun incelenmesi. ISPEC International Journal of Social Sciences & Humanities. 2021;5(2):189-203.
18. Bellikci Koyu E, Çalık G, Kaner Tohtak G, Günsel Yıldırım G. Sağlık çalışanlarının besin desteği kullanma durumları ve ilişkili etmenler. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi. 2020;34(2):141-151.
19. Rovira MA, Grau M, Castañer O, Covas MI, Schröder H; REGICOR Investigators. Dietary supplement use and healthrelated behaviors in a Mediterranean population. J Nutr Educ Behav. 2013;45(5):386-391.
20. Li K, Kaaks R, Linseisen J, Rohrmann S. Consistency of vitamin and/or mineral supplement use and demographic, lifestyle and health-status predictors: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)- Heidelberg cohort. Br J Nutr. 2010;104(7):1058-1064.
21. Marques-Vidal P, Vollenweider P, Waeber G. Trends in vitamin, mineral and dietary supplement use in Switzerland. The CoLaus study. Eur J Clin Nutr. 2017;71(1):122-127.
22. Mestaghanmi H, Labriji A, Kehailou FZ, Sabri A, Barka CA, Bouzoubaa H, et al. Study of the association between the consumption of dietary supplements and lifestyle factors in a population of Moroccan academics during the COVID 19 health crisis. Open Access Library Journal. 2021;8(6):1-30.
23. Tarı Selçuk K, Şahin N. COVID-19 salgını sürecinde yetişkinlerde gıda takviyesi kullanımı ve ilişkili etmenler. Turkish Journal of Family Medicine and Primary Care. 2021;15(4):751-762.
24. Kaner Tohtak G, Çalık G. COVID-19 pandemi sürecinde beslenme yönetimi. Şenuzun Aykar F, editör. İç Hastalıkları Hemşireliği ve COVID 19. 1. Baskı. Ankara: Türkiye Klinikleri; 2020;19-24.
25. Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, Apostolopoulos V, Stojanovska L. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas. 2021;143:1-9.
26. Beigmohammadi MT, Bitarafan S, Abdollahi A, Amoozadeh L, Salahshour F, Mahmoodi Ali Abadi M, Soltani D, Motallebnejad ZA. The association between serum levels of micronutrients and the severity of disease in patients with COVID-19. Nutrition. 2021;91-92:111400.
27. Kazemi A, Mohammadi V, Aghababaee SK, Golzarand M, Clark CCT, Babajafari S. Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: A systematic review and meta-analysis. Adv Nutr. 2021;12(5):1636-1658.
28. Wang Z, Joshi A, Leopold K, Jackson S, Christensen S, Nayfeh T, Mohammed K, Creo A, Tebben P, Kumar S. Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis. Clin Endocrinol (Oxf). 2022;96(3):281-287.
29. Tomasa-Irriguible TM, Bielsa-Berrocal L. COVID-19: Up to 82% critically ill patients had low vitamin C values. Nutr J. 2021;20(1):66.
30. Tian J, Tang L, Liu X, Li Y, Chen J, Huang W, Liu M. Populations in low-magnesium areas were associated with higher risk of infection in COVID-19’s early transmission: A nationwide retrospective cohort study in the United States. Nutrients. 2022;14(4):909.
31. Suna G, Çiftçi S. Should herbal supplements be used in the COVID-19 pandemic? Current Perspectives on Health Sciences. 2021;2(2):66-73.
32. Kutlu N, Ekin MM, Alav A, Ceylan Z, Meral R. Covid-19 pandemi sürecinde bireylerin beslenme alışkanlığında meydana gelen değişimin belirlenmesi üzerine bir araştırma. International Journal of Social, Political and Economic Research. 2021;8(1):173-187.
33. Kamarli Altun H, Karacil Ermumcu MS, Seremet Kurklu N. Evaluation of dietary supplement, functional food and herbal medicine use by dietitians during the COVID-19 pandemic. Public Health Nutr. 2021;24(5):861-869.
34. El Alami A, Fattah A, Chait A. Medicinal plants used for the prevention purposes during the COVID-19 pandemic in Morocco. J Anal Sci Appl Biotechnol. 2020;2(1):4-11.
35. Alyami HS, Orabi MAA, Aldhabbah FM, Alturki HN, Aburas WI, Alfayez AI, Alharbi AS, Almasuood RA, Alsuhaibani NA. Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia. Saudi Pharm J. 2020;28(11):1326-1332.
36. Zhao A, Li Z, Ke Y, Huo S, Ma Y, Zhang Y, Zhang J, Ren Z. Dietary diversity among Chinese residents during the COVID-19 outbreak and its associated factors. Nutrients. 2020;12(6):1699.
37. Flook M, Jackson C, Vasileiou E, Simpson CR, Muckian MD, Agrawal U, McCowan C, Jia Y, Murray JLK, Ritchie LD, Robertson C, Stock SJ, Wang X, Woolhouse MEJ, Sheikh A, Stagg HR. Informing the public health response to COVID-19: A systematic review of risk factors for disease, severity, and mortality. BMC Infect Dis. 2021;21(1):342.
38. Khan MA, Menon P, Govender R, Abu Samra AM, Allaham KK, Nauman J, Östlundh L, Mustafa H, Smith JEM, AlKaabi JM. Systematic review of the effects of pandemic confinements on body weight and their determinants. Br J Nutr. 2022;127(2):298-317.
39. Dinçer S, Kolcu M. Covid-19 pandemisinde toplumun beslenme alışkanlıklarının incelenmesi: İstanbul örneği. Turk J Diab Obes. 2021;2:193-201.
40. Saraçoğlu E, Aydın Avcı İ. Diyabet hastalarının Covid-19 salgınıyla ilgili endişelerinin ve bakım ihtiyaçlarının belirlenmesi.i. Turk J Diab Obes 2021;2: 202-209.
41. Biamonte E, Pegoraro F, Carrone F, Facchi I, Favacchio G, Lania AG, Mazziotti G, Mirani M. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine. 2021;72(3):604- 610.
42. Alshahrani SM, Alghannam AF, Taha N, Alqahtani SS, Al-Mutairi A, Al-Saud N, Alghnam S. The impact of COVID-19 pandemic on weight and body mass index in Saudi Arabia: A longitudinal study. Front Public Health. 2022;9:775022.
43. M Tourkmani A, J ALHarbi T, Rsheed AMB, Alrasheedy AA, ALMadani W, ALJuraisi F, AlOtaibi AF, AlHarbi M, AlAbood AF, Alshaikh AA. The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications. J Telemed Telecare. 2021;1357633X20985763.
44. Bonora BM, Boscari F, Avogaro A, Bruttomesso D, Fadini GP. Glycaemic control among people with Type 1 Diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. Diabetes Ther. 2020;11(6):1369-1379.
45. Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: A prospective, observational, nested cohort study. Int J Diabetes Dev Ctries. 2020;40(4):476-481.